Broadrick Dale's Form 4 filing
BioRestorative Therapies, Inc. (BRTX) · filed Jul 15, 2022
- Accession no.
- 0001567619-22-014051
- Filed
- Jul 15, 2022
- Trade date
- Jul 6-13, 2022
- Filing delay
- 9 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $3.61K. It was filed 9 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Broadrick DaleCIK 0001677513 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2022 | Common Stock | PPurchaseAcquired | +100 | $3.38 | +$338 | 297,473 | Direct | |
| Jul 12, 2022 | Common Stock | PPurchaseAcquired | +900 | $2.97F1 | +$2,673 | 298,373 | Direct | |
| Jul 13, 2022 | Common Stock | PPurchaseAcquired | +200 | $3.00 | +$600 | 298,573 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $2.95 to $2.9799 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.